ACADIAN ASSET MANAGEMENT LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 44 filers reported holding CTI BIOPHARMA CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2020$19,000
-89.5%
20,524
-52.3%
0.00%
-100.0%
Q1 2017$181,000–43,044–0.00%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2020.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders